Bacterin International Holdings BONE today announced that the United States Patent and
Trademark Office has issued US Patent No. 8,574,825 entitled “Process
for Demineralization of Bone Matrix with Preservation of Natural Growth
Factors.” The issued claims in the patent are for a method to produce a
demineralized cancellous bone matrix, such as Bacterin's OsteoSponge®
product line. Bacterin has a pending divisional application in the
United States to pursue protection on other aspects of its bone
demineralization technology and is pursuing protection on related
applications in Canada, Europe, and Korea.
Gregory Juda, Bacterin's CSO, commented “We are pleased
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in